1.09 USD
↗ 0.03 (2.83%)LIVE (AS OF 03:58 PM EDT)
Biofrontera Inc. Common Stock
BFRINASDAQ • USD
Market: OPEN
BFRI is currently priced at $1.09. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Key drivers include a concerning Altman Z-Score in the distress zone, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, BFRI appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 14, 2026.
Open?$1.06
High?$1.10
Low?$1.05
Prev. Close?$1.06
Volume?152.0K
Avg. Volume?326.6K
VWAP?$1.07
Rel. Volume?0.47x
Bid / Ask
Bid?$0.94 × 100
Ask?$1.25 × 100
Spread?$0.31
Midpoint?$1.09
Valuation & Ratios
Market Cap?13.6M
Shares Out?12.8M
Float?11.3M
Float %?88.3%
P/E Ratio?N/A
P/B Ratio?2.24
EPS?-$0.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
Employees
94
Market Cap
13.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-10-29
Address
120 PRESIDENTIAL WAY,
WOBURN, MA 01801
Phone: 781-245-1325
WOBURN, MA 01801
Phone: 781-245-1325
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?0
Momentum?8
Short Sent.?80
Piotroski F-Score?3/9Weak
Altman Z-Score?-6.69Distress
Confidence?46%Low
Short InterestLow
Short % of Float?0.25%Low
Short Interest?27.9K
Days to Cover?1.0
Free Float11.3M
Avg Daily Volume314.2K
Settlement Date2026-06-30
Financial Health
Current Ratio?1.20Adequate
Quick Ratio?1.09Adequate
Cash Ratio?0.58Adequate
Debt/Equity?0.78Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.24CHEAP▾
Peers100
S&P69
P/S?0.31CHEAP▾
Peers100
S&P97
P/FCF?N/A▾
EV/EBITDA?-1.1CHEAP▾
S&P97
EV/Sales?0.28CHEAP▾
Peers100
S&P97
Returns & Efficiency
ROE?-182.6%WEAK▾
S&P3
ROA?-44.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-9318000
Enterprise Value?$12.0M
Fundamentals ratios updated end of day